An experimental gene therapy based on interleukin-10 is showing promise in dogs with severe osteoarthritis, reducing pain and inflammation and restoring their ability to move, and it could reduce the need for joint replacements in humans, says University of Colorado Boulder neuroscience professor Linda Watkins. More dogs are being accepted into clinical trials, and the FDA recently approved the experimental therapy for human use.
Gene therapy reduces pain, inflammation in dogs with osteoarthritis
Sign up for Animal Health SmartBrief
News for animal health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.